Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials

Type 1 Gaucher disease is an inherited lysosomal enzyme deficiency with variable age of symptom onset. Common presenting signs include thrombocytopenia, anemia, hepatosplenomegaly, bone abnormalities, and, additionally in children, growth failure. Fifty-seven patients aged 3–62 years at the baseline...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Derralynn A, Gonzalez, Derlis E, Lukina, Elena A, Mehta, Atul, Kabra, Madhulika, Elstein, Deborah, Kisinovsky, Isaac, Giraldo, Pilar, Bavdekar, Ashish, Hangartner, Thomas N, Wang, Nan, Crombez, Eric, Zimran, Ari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654249/
https://www.ncbi.nlm.nih.gov/pubmed/25801797
http://dx.doi.org/10.1002/ajh.24012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654249/
https://www.ncbi.nlm.nih.gov/pubmed/25801797
http://dx.doi.org/10.1002/ajh.24012

Ejemplares similares